{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:27:27Z","timestamp":1789576047733,"version":"build-2803163510"},"reference-count":31,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T00:00:00Z","timestamp":1693008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>This narrative review of the literature, consisting of papers found in PubMed and The Cochrane Library published up to 31 July 2023, analyzed those that were deemed to be closely related to the title of this paper. It was encountered that the peril of deep vein thrombosis (DVT) in people with hemophilia (PWH) after orthopedic surgery is very small, such that pharmacological thromboprophylaxis is not necessary in most cases. The hemophilia literature states that the use of pharmacological thromboprophylaxis should only be performed in PWH undergoing major orthopedic surgery (total-knee arthroplasty, total-hip arthroplasty, ankle arthrodesis) who have additional venous thromboembolism (VTE) risk factors, such as old age, prior VTE, varicose veins, general anesthesia, cancer, factor V (Leiden) mutation, overweight, and treatment with the oral contraceptive pill (in females with von Willebrand\u2019s illness). If we notice various risk factors for VTE in PWH who experience orthopedic surgery, theoretically, we should perform the identical type of pharmacological thromboprophylaxis advised for non-hemophilia patients: low-molecular weight heparins (LMWHs), such as enoxaparin (40 mg subcutaneous\/24 h); or direct oral anticoagulants (DOACs), either thrombin inhibitors (dabigatran, 150 mg oral\/12 h) or activated factor X (FXa) inhibitors (rivaroxaban, 20 mg oral\/24 h; apixaban, 5 mg oral\/24 h), or subcutaneous fondaparinux (2.5 mg\/24 h subcutaneously). However, the review of the literature on hemophiliac patients has shown that only a few authors have used pharmacological prophylaxis with LMWH (subcutaneous enoxaparin) for a short period of time (10\u201314 days) in some patients who had risk factors for VTE. Only one group of authors used a low dose of DOAC in the dusk after the surgical procedure and the next day, specifically in individuals at elevated risk of VTE and elevated risk of bleeding after the surgical procedure.<\/jats:p>","DOI":"10.3390\/jcm12175574","type":"journal-article","created":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T05:46:47Z","timestamp":1693201607000},"page":"5574","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pharmacological Thromboprophylaxis in People with Hemophilia Experiencing Orthopedic Surgery: What Does the Literature Say in 2023?"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6360-0113","authenticated-orcid":false,"given":"Emerito Carlos","family":"Rodriguez-Merchan","sequence":"first","affiliation":[{"name":"Department of Orthopedic Surgery, La Paz University Hospital\u2014Idipaz, 28046 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,8,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3390\/hematolrep15020039","article-title":"Managing relevant clinical conditions of hemophilia A\/B patients","volume":"15","author":"Morfini","year":"2023","journal-title":"Hematol. Rep."},{"key":"ref_2","first-page":"41","article-title":"The incidence of symptomatic venous thromboembolism following orthopaedic surgery at Bay of Plenty District Health Board","volume":"136","author":"Read","year":"2023","journal-title":"N. Z. Med. J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1302\/2058-5241.6.200120","article-title":"Prevention of venous thromboembolism with aspirin following knee surgery: A systematic review and meta-analysis","volume":"6","author":"Marrannes","year":"2021","journal-title":"EFORT Open Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.thromres.2020.12.007","article-title":"Thromboprophylaxis for orthopedic surgery; An updated meta-analysis","volume":"199","author":"Haykal","year":"2021","journal-title":"Thromb. Res."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Fu, D., Li, L., Li, Y., Liu, X., Chen, H., Wu, N., and Sun, G. (2022). Fondaparinux sodium and low molecular weight heparin for venous thromboembolism prophylaxis in Chinese patients with major orthopedic surgery or trauma: A real-world study. BMC Surg., 22.","DOI":"10.1186\/s12893-022-01652-6"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.vhri.2020.08.002","article-title":"Multi-criteria model for evaluating drugs to prevent deep venous thrombosis associated with orthopedic surgery: A hospital-based case study","volume":"23","author":"Morais","year":"2020","journal-title":"Value Health Reg. Issues"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e227S","DOI":"10.1378\/chest.11-2297","article-title":"Prevention of VTE in nonorthopedic surgical patients: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Gould","year":"2012","journal-title":"Chest"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1016\/j.mayocp.2020.06.015","article-title":"Perioperative venous thromboembolism prophylaxis","volume":"95","author":"Bartlett","year":"2020","journal-title":"Mayo Clin. Proc."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.arth.2019.08.049","article-title":"Have venous thromboembolism rates decreased in total hip and knee arthroplasty?","volume":"35","author":"Warren","year":"2020","journal-title":"J. Arthroplast."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/jth.15132","article-title":"Preventing VTE following total hip and knee arthroplasty: Is prediction the future?","volume":"19","author":"Nemeth","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s11096-020-01032-1","article-title":"Aspirin compared to enoxaparin or rivaroxaban for thromboprophylaxis following hip and knee replacement","volume":"42","author":"Fleming","year":"2020","journal-title":"Int. J. Clin. Pharm."},{"key":"ref_12","first-page":"e19691","article-title":"Efficacy and safety of thromboprophylaxis post-orthopedic surgery","volume":"13","author":"Alsheikh","year":"2021","journal-title":"Cureus"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.arth.2021.11.030","article-title":"Enoxaparin versus direct oral anticoagulants for venous thromboembolism in Asians undergoing total knee arthroplasty: A meta-analysis and systematic review","volume":"37","author":"Chua","year":"2022","journal-title":"J. Arthroplast."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1076029620962226","DOI":"10.1177\/1076029620962226","article-title":"Potential risk factors contributing to development of venous thromboembolism for total knee replacements patients prophylaxed with rivaroxaban: A retrospective case-control study","volume":"26","author":"Mian","year":"2020","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e040336","DOI":"10.1136\/bmjopen-2020-040336","article-title":"Bleeding complications of thromboprophylaxis with dabigatran, nadroparin or rivaroxaban for 6 weeks after total knee arthroplasty surgery: A randomised pilot study","volume":"11","author":"Segers","year":"2021","journal-title":"BMJ Open"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1177\/1120700019841600","article-title":"Venous thromboprophylaxis after total hip arthroplasty: Aspirin, warfarin, enoxaparin, or factor Xa inhibitors?","volume":"30","author":"Bala","year":"2020","journal-title":"Hip Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1302\/0301-620X.102B7.BJJ-2019-1559.R1","article-title":"Multimodal prophylaxis in patients with a history of venous thromboembolism undergoing primary elective hip arthroplasty","volume":"102-B","author":"Shanaghan","year":"2020","journal-title":"Bone Jt. J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1016\/j.otsr.2019.05.026","article-title":"Thrombotic risk in children undergoing orthopedic surgery","volume":"106","author":"Odent","year":"2020","journal-title":"Orthop. Traumatol. Surg. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1046\/j.1365-2516.2000.00431.x","article-title":"Venous thromboembolism after hip fracture surgery in a patient with haemophilia B and factor V Arg506Gln (factor V Leiden)","volume":"6","author":"Pruthi","year":"2000","journal-title":"Haemophilia"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.thromres.2012.08.265","article-title":"Surgery in patients with hemophilia: Is thromboprophylaxis mandatory?","volume":"130","author":"Ozelo","year":"2012","journal-title":"Thromb Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1055\/s-0037-1619775","article-title":"Incidence of thromboembolic events after major operations in patients with haemophilia","volume":"32","author":"Krekeler","year":"2012","journal-title":"Hamostaseologie"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/MBC.0000000000000064","article-title":"Thromboprophylaxis in haemophilia patients undergoing orthopaedic surgery","volume":"25","year":"2014","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/hae.12387","article-title":"Management of orthopaedic surgery in rare bleeding disorders","volume":"20","author":"Siboni","year":"2014","journal-title":"Haemophilia"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/hae.12643","article-title":"Deep venous thrombosis was not detected after total knee arthroplasty in Japanese patients with haemophilia","volume":"21","author":"Takedani","year":"2015","journal-title":"Haemophilia"},{"key":"ref_25","first-page":"84","article-title":"Multicentric and international study evaluating clinical and subclinical venous thrombosis in patients with haemophilia undergoing major orthopaedic surgery","volume":"Volume 22","author":"Hermans","year":"2016","journal-title":"Haemophilia"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1160\/TH15-10-0802","article-title":"Prospective, multicenter study of postoperative deep-vein thrombosis in patients with haemophilia undergoing major orthopaedic surgery","volume":"116","author":"Buckner","year":"2016","journal-title":"Thromb. Haemost."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1177\/1076029616643821","article-title":"Thromboprophylaxis and outcomes for total joint arthroplasty in congenital bleeding disorders: A single-center experience","volume":"22","author":"Holderness","year":"2016","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/1076029614543139","article-title":"Thromboprophylaxis and incidence of venous thromboembolism in patients with hemophilia A or B who underwent high-risk orthopedic surgeries","volume":"22","author":"Raza","year":"2016","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/EJA.0000000000000725","article-title":"European guidelines on perioperative venous thromboembolism prophylaxis: Patients with preexisting coagulation disorders and after severe perioperative bleeding","volume":"35","author":"Ahmed","year":"2018","journal-title":"Eur. J. Anaesthesiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/hae.14161","article-title":"Low rate of subclinical venous thrombosis in patients with haemophilia undergoing major orthopaedic surgery in the absence of pharmacological thromboprophylaxis","volume":"26","author":"Verstraete","year":"2020","journal-title":"Haemophilia"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/hae.14095","article-title":"Risk of deep venous thrombosis after total knee arthroplasty in patients with haemophilia A","volume":"26","author":"Ono","year":"2020","journal-title":"Haemophilia"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/17\/5574\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:39:52Z","timestamp":1760128792000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/17\/5574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,26]]},"references-count":31,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["jcm12175574"],"URL":"https:\/\/doi.org\/10.3390\/jcm12175574","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,26]]}}}